Mechanism of tau hyperphosphorylation in brain cortex of diabetic rats and effect of LiCl

Acta Academiae Medicinae Sinicae

Volumn 28, Issue 2, 2006, Pages 244-248

  Qu, Zhong Sen ^a   Tian, Qing ^a   Zhou, Xin Wen ^a   Wang, Qun ^a   Zhang, Qi ^a   Wang, Jian Zhi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Diabetes; Glycogen synthase kinase 3; LiCl; Tau protein

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; LITHIUM CHLORIDE; PHOSPHORUS 32; SODIUM CHLORIDE; STREPTOZOCIN; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME INHIBITION; ISOTOPE LABELING; MEMORY CONSOLIDATION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; CEREBRAL CORTEX; DIABETES MELLITUS, EXPERIMENTAL; GLYCOGEN SYNTHASE KINASE 3; LITHIUM CHLORIDE; MALE; MEMORY DISORDERS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; TAU PROTEINS;

EID: 33744797098     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Peila R, Rodriguez BL, launer LJ, et al. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging study. Diabetes, 2002, 51(4): 1256-1262.
2. Sheng SL, Zhao YM, Zhao ZW, et al. Beta-amyloid and its binding protein in the hippocampus of diabetic mice: effect of APP 17 peptide. Neuroreport, 2001, 12(15):3317-3319.
3. Kaidanovich O, Eldar-Finkelman H. The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Expert Opin Ther Targets, 2002, 6(5):555-561.
4. Ring DB, Johnson KW, Heriksen EJ, et al. Selective glycogen synthase kinase 3 inhibitor potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes, 2003, 52(3):588-595.
5. Nikoulina SE, Ciaraldi TP, Mudaliar S, et al. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes, 2000, 49(2):263-271.
6. Liu SJ, Zhang AH, Li HL, et al. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J Neurochem, 2003, 87 (6): 1333-1344.
7. Grundke-Iqbal I, Iqbal K, Tung YC, et al. Abnormal phosphorylation of the microtuble-associated protein tau in Alzheimer cytoskeleton pathology. Proc Natl Acad Sci USA, 1986, 83 (13):4913-4917.
8. Zhao YM, Pei JJ, Ji ZJ, et al. Effect of amyloid precursor protein 17 mer peptide on microtubule structure and tau protein hyperphosphorylation in hippocampal neurons of experimental diabetic mice. Neuroreport, 2003, 14(1):61-66.
9. Raza H, Ahmed I, John A, et al. Tissue specific expression and immunohistochemical localization of glutathione S-transferase in streptoiocin induced diabetic rats: modulation by momordica charantia (karela) extract. Life Sci, 2004, 74(12): 1503-1511.
10. Stambolic V, Ruel L, Woodgett JR, et al. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signaling in intact cells. Curr Biol, 1996, 6(12):1644-1668.
11. Wang JZ, Gong CX, Zaidi T, et al. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and 2B. J Biol Chem, 1995, 270(9):4854-4860.
12. Wang JZ, Wu Q, Smith A, et al. Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett, 1998, 436(1):28-34.
13. Havens WW, Cole J. Successful treatment of dementia with lithium. J Clin Psychopharmacol, 1982, 2(1):71-72.